CoChat

The Synergistic Effect of 5-Aza-2′-Deoxycytidine and 5-Fluorouracil on Drug-Resistant Tumors

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Purpose: We investigated whether a 5-fluorouracil (5-FU)-resistant tumor could regain chemosensitivity after the administration of 5-aza-2′-deoxycytidine (DAC) as a demethylating agent. Methods: Human colorectal cancer cells (SW48) are characterized by the hypermethylation of proapoptotic genes. They were transplanted into 20 athymic BALB/c nu/nu mice which were randomly placed into 4 groups (1 = control; 2 = 5-FU alone; 3 = DAC alone; 4 = DAC followed by 5-FU). We evaluated the synergistic effect of DAC and 5-FU on the growth of these xenografts. Reactivation of proapoptotic genes in these cells was analyzed by methylation-specific PCR. Gene expression was determined by a quantitative reverse-transcription PCR assay. Results: Compared with the control group, relative tumor volumes were statistically significantly decreased only in group 4 mice (p = 0.006). In groups 3 and 4, p14, p16 and death-associated protein kinase (DAPK) promoter regions were demethylated and p14 gene expression was gradually increased after DAC administration. Conclusion: DAC could be a useful medicine that breaks the silencing of various genes and recovers some expressions. By pretreating with DAC at a nontoxic level, we confirmed the restoration of 5-FU chemosensitivity and apoptosis induction. The combination of demethylating agents and several cytotoxic drugs has potential in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1159/000107110

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 30

Metadata

Authors
Morita, S., Iida, S., Kato, K., Takagi, Y., Uetake, H., & Sugihara, K.
Affiliations
Tokyo Medical and Dental University (JP)
Venue
Oncology
Publisher
S. Karger AG
Published
2006
Volume
71
Issue
5-6
Pages
437-445
ISSN
  • 0030-2414 (ISSN-L)
  • 1423-0232
OpenAlex
W2069096225
Cited by
29
References
39
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 3 · 2012: 4
FWCI
1.08
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Keywords
decitabine, 5-fluorouracil, drug resistance, colorectal cancer, DNA methylation, hypomethylating agents, gene reactivation, p14, p16, DAPK, apoptosis, drug synergy, xenograft tumor growth
MeSH terms
Decitabine, Animals, Azacitidine, Drug Synergism, Fluorouracil, Humans, Mice, Nude, Colorectal Neoplasms, Up-Regulation, Apoptosis, Calcium-Calmodulin-Dependent Protein Kinases, Drug Resistance, Neoplasm, DNA Methylation, Cyclin-Dependent Kinase Inhibitor p16, Reverse Transcriptase Polymerase Chain Reaction, Xenograft Model Antitumor Assays, Tumor Suppressor Protein p14ARF, Cell Line, Tumor, Cell Proliferation, Apoptosis Regulatory Proteins, Mice, Death-Associated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Synergistic Effect of 5-Aza-2′-Deoxycytidine and 5-Fluorouracil on Drug-Resistant Tumors. https://app.cochat.ai/papers/10.1159/000107110
The paper
Morita, S., Iida, S., Kato, K., Takagi, Y., Uetake, H., & Sugihara, K. (2006). The Synergistic Effect of 5-Aza-2′-Deoxycytidine and 5-Fluorouracil on Drug-Resistant Tumors. Oncology. https://doi.org/10.1159/000107110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.